Kolexia
Bruckert Eric Endocrinologie
Bruckert Eric
Endocrinologie
Cds Ellasante
Paris, France
429 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hypercholestérolémie Hyperlipoprotéinémie de type II Athérosclérose Dyslipidémies Diabète de type 2 Accident vasculaire cérébral Prédisposition génétique à une maladie Hypercholestérolémie familiale homozygote Maladie des artères coronaires

Collaborateurs

Voir plus
Ferrieres Jean
Ferrieres Jean
Hôpital Rangueil, Toulouse, France
Farnier Michel
Farnier Michel
Cabinet libéral, Dijon, France
Gallo Antonio
Gallo Antonio
Hôpital Pitie Salpetriere, Paris, France
Krempf Michel
Krempf Michel
Hôpital Laennec, Saint-Herblain, France

Industries

Voir plus
Servier
62 collaboration(s)
Dernière en 2023
Novartis
25 collaboration(s)
Dernière en 2023
Amgen
16 collaboration(s)
Dernière en 2022
Sanofi
14 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
ORION-13: Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Adolescents (12 to Less Than 18 Years) With Homozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol (ORION-13)
Essai Clinique (Novartis)   21 mars 2024
ORION-16: Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Adolescents (12 to Less Than 18 Years) With Heterozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol (ORION-16)
Essai Clinique (Novartis)   22 décembre 2023
Treatment of pediatric heterozygous familial hypercholesterolemia: Where do we stand in real-world study in France seven years after the recommendations of the european atherosclerosis society (EAS)?
Clinical nutrition ESPEN   01 décembre 2023
Age- and sex-based heterogeneity in coronary artery plaque presence and burden in familial hypercholesterolemia: A multi-national study.
American journal of preventive cardiology   23 novembre 2023
Establishing a multi-specialty consensus in the clinical need for hypercholesterolemia management and its implication for patients access to innovative therapies.
Panminerva medica   18 octobre 2023
PHYTOPLAQUES: Effect of Phytosterols Enriched Products Consumption on Carotid Artery Artherosclerotic Plaque
Essai Clinique (Société Française de Cardiologie)   11 septembre 2023
A protocol for an international, multicenter, prospective, non-interventional observational registry for patients with hypertriglyceridemia.
Current medical research and opinion   04 septembre 2023
Qu'appelle-t-on Hypercholestérolémie familiale homozygote ou HoFH ?
Youtube @ RARE à l'écoute   01 septembre 2023
Observed consensus on research priorities for the hypertriglyceridemia patient registry.
Current medical research and opinion   02 août 2023
The smash program: An initiative for greater access to innovations for rare or severe hyperlipidemia
EAS Abstracts 2023   01 août 2023